Global Lyme Disease Testing Production, Demand and Key Producers, 2022-2028

December 2022 | 110 pages | ID: G4A2EA9359F7EN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Lyme disease is caused by the bacterium Borrelia burgdorferi and rarely, Borrelia mayonii. It is transmitted to humans through the bite of infected blacklegged ticks. Typical symptoms include fever, headache, fatigue, and a characteristic skin rash called erythema migrans. Lyme disease is usually diagnosed by serology. RIPL uses a modified 2-tier testing approach. The initial screening test is a combined IgG and IgM ELISA that detects antibodies against 2 Borrelia burgdorferi antigens – VlsE1 and pepC10.

This report studies the global Lyme Disease Testing demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Lyme Disease Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Lyme Disease Testing that contribute to its increasing demand across many markets.

The global Lyme Disease Testing market size is expected to reach $ 316.6 million by 2028, rising at a market growth of 6.3% CAGR during the forecast period (2022-2028).

Highlights and key features of the study

Global Lyme Disease Testing total market, 2017-2028, (USD Million)

Global Lyme Disease Testing total market by region & country, CAGR, 2017-2028, (USD Million)

U.S. VS China: Lyme Disease Testing total market, key domestic companies and share, (USD Million)

Global Lyme Disease Testing revenue by player and market share 2017-2022, (USD Million)

Global Lyme Disease Testing total market by Type, CAGR, 2017-2028, (USD Million)

Global Lyme Disease Testing total market by Application, CAGR, 2017-2028, (USD Million)

This reports profiles major players in the global Lyme Disease Testing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Quidel Corporation, Roche Holding AG, Fujirebio(H.U. Group Holdings), ZEUS Scientific, IGeneX, Thermo Fisher Scientific, Everlywell, Oxford Immunotec Global PLC(PerkinElmer) and BioMerieux, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Lyme Disease Testing market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.

Global Lyme Disease Testing Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global Lyme Disease Testing Market, Segmentation by Type
  • ELISA
  • Western Blotting
  • PCR
  • Others
Global Lyme Disease Testing Market, Segmentation by Application
  • Hospital and Testing Agency
  • Personal
Companies Profiled:
  • Quidel Corporation
  • Roche Holding AG
  • Fujirebio(H.U. Group Holdings)
  • ZEUS Scientific
  • IGeneX
  • Thermo Fisher Scientific
  • Everlywell
  • Oxford Immunotec Global PLC(PerkinElmer)
  • BioMerieux
  • Bio-Rad Laboratories
  • T2 Biosystems
Key Questions Answered

1. How big is the global Lyme Disease Testing market?

2. What is the demand of the global Lyme Disease Testing market?

3. What is the year over year growth of the global Lyme Disease Testing market?

4. What is the total value of the global Lyme Disease Testing market?

5. Who are the major players in the global Lyme Disease Testing market?

6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 Lyme Disease Testing Introduction
1.2 World Lyme Disease Testing Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Lyme Disease Testing Total Market by Region
  1.3.1 World Lyme Disease Testing Market Size by Region (2017-2028)
  1.3.2 United States Lyme Disease Testing Market Size (2017-2028)
  1.3.3 China Lyme Disease Testing Market Size (2017-2028)
  1.3.4 Europe Lyme Disease Testing Market Size (2017-2028)
  1.3.5 Japan Lyme Disease Testing Market Size (2017-2028)
  1.3.6 South Korea Lyme Disease Testing Market Size (2017-2028)
  1.3.7 ASEAN Lyme Disease Testing Market Size (2017-2028)
  1.3.8 India Lyme Disease Testing Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Lyme Disease Testing Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Lyme Disease Testing Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 WORLD LYME DISEASE TESTING COMPANIES COMPETITIVE ANALYSIS

2.1 World Lyme Disease Testing Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
  2.2.1 Global Lyme Disease Testing Industry Rank of Major Players
  2.2.2 Global Concentration Ratios (CR4) for Lyme Disease Testing in 2021
  2.2.3 Global Concentration Ratios (CR8) for Lyme Disease Testing in 2021
2.3 Lyme Disease Testing Company Evaluation Quadrant
2.4 Lyme Disease Testing Market: Overall Company Footprint Analysis
  2.4.1 Lyme Disease Testing Market: Region Footprint
  2.4.2 Lyme Disease Testing Market: Company Product Type Footprint
  2.4.3 Lyme Disease Testing Market: Company Product Application Footprint
2.5 Competitive Environment
  2.5.1 Historical Structure of the Industry
  2.5.2 Barriers of Market Entry
  2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity

3 UNITED STATES VS CHINA VS REST OF THE WORLD

3.1 United States VS China: Lyme Disease Testing Market Comparison
  3.1.1 United States VS China: Lyme Disease Testing Market Size Comparison (2017 & 2021 & 2028)
  3.1.2 United States VS China: Lyme Disease Testing Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Lyme Disease Testing Major Players and Market Share, 2017-2022
  3.2.1 Major Players of Lyme Disease Testing in United States, Headquarters (States, Country)
  3.2.2 United States Lyme Disease Testing Revenue by Domestic Player, (2017-2022)
3.3 China Lyme Disease Testing Major Players and Market Share, 2017-2022
  3.3.1 Major Players of Lyme Disease Testing in China, Headquarters (Province, Country)
  3.3.2 China Lyme Disease Testing Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Lyme Disease Testing Major Players and Market Share, 2017-2022
  3.4.1 Major Players of Lyme Disease Testing in Rest of World, Headquarters (State, Country)
  3.4.2 Rest of World Lyme Disease Testing Revenue by Domestic Player, (2017-2022)

4 MARKET ANALYSIS BY TYPE

4.1 World Lyme Disease Testing Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
  4.2.1 ELISA
  4.2.2 Western Blotting
  4.2.3 PCR
  4.2.4 Others
4.3 Market Segment by Type
  4.3.1 World Lyme Disease Testing Market Size by Type (2017-2022)
  4.3.2 World Lyme Disease Testing Market Size by Type (2023-2028)
  4.3.3 World Lyme Disease Testing Market Size Market Share by Type (2017-2028)

5 MARKET ANALYSIS BY APPLICATION

5.1 World Lyme Disease Testing Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
  5.2.1 Hospital and Testing Agency
  5.2.2 Personal
5.3 Market Segment by Application
  5.3.1 World Lyme Disease Testing Market Size by Application (2017-2022)
  5.3.2 World Lyme Disease Testing Market Size by Application (2023-2028)
  5.3.3 World Lyme Disease Testing Market Size by Application (2017-2028)

6 COMPANY PROFILES

6.1 Quidel Corporation
  6.1.1 Quidel Corporation Details
  6.1.2 Quidel Corporation Major Business
  6.1.3 Quidel Corporation Lyme Disease Testing Product and Services
  6.1.4 Quidel Corporation Lyme Disease Testing Revenue, Gross Margin and Market Share (2017-2022)
  6.1.5 Quidel Corporation Recent Developments/Updates
  6.1.6 Quidel Corporation Competitive Strengths & Weaknesses
6.2 Roche Holding AG
  6.2.1 Roche Holding AG Details
  6.2.2 Roche Holding AG Major Business
  6.2.3 Roche Holding AG Lyme Disease Testing Product and Services
  6.2.4 Roche Holding AG Lyme Disease Testing Revenue, Gross Margin and Market Share (2017-2022)
  6.2.5 Roche Holding AG Recent Developments/Updates
  6.2.6 Roche Holding AG Competitive Strengths & Weaknesses
6.3 Fujirebio(H.U. Group Holdings)
  6.3.1 Fujirebio(H.U. Group Holdings) Details
  6.3.2 Fujirebio(H.U. Group Holdings) Major Business
  6.3.3 Fujirebio(H.U. Group Holdings) Lyme Disease Testing Product and Services
  6.3.4 Fujirebio(H.U. Group Holdings) Lyme Disease Testing Revenue, Gross Margin and Market Share (2017-2022)
  6.3.5 Fujirebio(H.U. Group Holdings) Recent Developments/Updates
  6.3.6 Fujirebio(H.U. Group Holdings) Competitive Strengths & Weaknesses
6.4 ZEUS Scientific
  6.4.1 ZEUS Scientific Details
  6.4.2 ZEUS Scientific Major Business
  6.4.3 ZEUS Scientific Lyme Disease Testing Product and Services
  6.4.4 ZEUS Scientific Lyme Disease Testing Revenue, Gross Margin and Market Share (2017-2022)
  6.4.5 ZEUS Scientific Recent Developments/Updates
  6.4.6 ZEUS Scientific Competitive Strengths & Weaknesses
6.5 IGeneX
  6.5.1 IGeneX Details
  6.5.2 IGeneX Major Business
  6.5.3 IGeneX Lyme Disease Testing Product and Services
  6.5.4 IGeneX Lyme Disease Testing Revenue, Gross Margin and Market Share (2017-2022)
  6.5.5 IGeneX Recent Developments/Updates
  6.5.6 IGeneX Competitive Strengths & Weaknesses
6.6 Thermo Fisher Scientific
  6.6.1 Thermo Fisher Scientific Details
  6.6.2 Thermo Fisher Scientific Major Business
  6.6.3 Thermo Fisher Scientific Lyme Disease Testing Product and Services
  6.6.4 Thermo Fisher Scientific Lyme Disease Testing Revenue, Gross Margin and Market Share (2017-2022)
  6.6.5 Thermo Fisher Scientific Recent Developments/Updates
  6.6.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
6.7 Everlywell
  6.7.1 Everlywell Details
  6.7.2 Everlywell Major Business
  6.7.3 Everlywell Lyme Disease Testing Product and Services
  6.7.4 Everlywell Lyme Disease Testing Revenue, Gross Margin and Market Share (2017-2022)
  6.7.5 Everlywell Recent Developments/Updates
  6.7.6 Everlywell Competitive Strengths & Weaknesses
6.8 Oxford Immunotec Global PLC(PerkinElmer)
  6.8.1 Oxford Immunotec Global PLC(PerkinElmer) Details
  6.8.2 Oxford Immunotec Global PLC(PerkinElmer) Major Business
  6.8.3 Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Product and Services
  6.8.4 Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Revenue, Gross Margin and Market Share (2017-2022)
  6.8.5 Oxford Immunotec Global PLC(PerkinElmer) Recent Developments/Updates
  6.8.6 Oxford Immunotec Global PLC(PerkinElmer) Competitive Strengths & Weaknesses
6.9 BioMerieux
  6.9.1 BioMerieux Details
  6.9.2 BioMerieux Major Business
  6.9.3 BioMerieux Lyme Disease Testing Product and Services
  6.9.4 BioMerieux Lyme Disease Testing Revenue, Gross Margin and Market Share (2017-2022)
  6.9.5 BioMerieux Recent Developments/Updates
  6.9.6 BioMerieux Competitive Strengths & Weaknesses
6.10 Bio-Rad Laboratories
  6.10.1 Bio-Rad Laboratories Details
  6.10.2 Bio-Rad Laboratories Major Business
  6.10.3 Bio-Rad Laboratories Lyme Disease Testing Product and Services
  6.10.4 Bio-Rad Laboratories Lyme Disease Testing Revenue, Gross Margin and Market Share (2017-2022)
  6.10.5 Bio-Rad Laboratories Recent Developments/Updates
  6.10.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
6.11 T2 Biosystems
  6.11.1 T2 Biosystems Details
  6.11.2 T2 Biosystems Major Business
  6.11.3 T2 Biosystems Lyme Disease Testing Product and Services
  6.11.4 T2 Biosystems Lyme Disease Testing Revenue, Gross Margin and Market Share (2017-2022)
  6.11.5 T2 Biosystems Recent Developments/Updates
  6.11.6 T2 Biosystems Competitive Strengths & Weaknesses

7 RAW MATERIAL AND INDUSTRY CHAIN

7.1 Raw Material of Lyme Disease Testing and Key Manufacturers
7.2 Lyme Disease Testing Manufacturing Costs
7.3 Lyme Disease Testing Production Process
7.4 Lyme Disease Testing Industrial Chain

8 DISTRIBUTION CHANNEL ANALYSIS

8.1 Distribution Channel Breakdown for Lyme Disease Testing Shipments (%): 2017-2028
  8.1.1 Direct Channel
  8.1.2 Indirect Channel
8.2 Lyme Disease Testing Typical Distributors
8.3 Lyme Disease Testing Typical Customers

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

LIST OF TABLES

Table 1. World Lyme Disease Testing Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Lyme Disease Testing Market Size by Region (2017-2022) & (USD Million)
Table 3. World Lyme Disease Testing Market Size by Region (2023-2028) & (USD Million)
Table 4. World Lyme Disease Testing Market Size Market Share by Region (2017-2022)
Table 5. World Lyme Disease Testing Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Lyme Disease Testing Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Lyme Disease Testing Players in 2021
Table 9. World Lyme Disease Testing Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Lyme Disease Testing Company Evaluation Quadrant
Table 11. Head Office of Key Lyme Disease Testing Player
Table 12. Lyme Disease Testing Market: Company Product Type Footprint
Table 13. Lyme Disease Testing Market: Company Product Application Footprint
Table 14. Lyme Disease Testing Mergers & Acquisitions Activity
Table 15. United States VS China Lyme Disease Testing Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Lyme Disease Testing in United States, Headquarters (States, Country)
Table 17. United States Lyme Disease Testing Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Lyme Disease Testing Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Lyme Disease Testing in China, Company Headquarters (Province, Country)
Table 20. China Lyme Disease Testing Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Lyme Disease Testing Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Lyme Disease Testing in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Lyme Disease Testing Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Lyme Disease Testing Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Lyme Disease Testing Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Lyme Disease Testing Revenue by Type (2017-2022) & (USD Million)
Table 27. World Lyme Disease Testing Revenue by Type (2023-2028) & (USD Million)
Table 28. World Lyme Disease Testing Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Lyme Disease Testing Revenue by Application (2017-2022) & (USD Million)
Table 30. World Lyme Disease Testing Revenue by Application (2023-2028) & (USD Million)
Table 31. Quidel Corporation Basic Information, Area Served and Competitors
Table 32. Quidel Corporation Major Business
Table 33. Quidel Corporation Lyme Disease Testing Product and Services
Table 34. Quidel Corporation Lyme Disease Testing Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Quidel Corporation Recent Developments/Updates
Table 36. Quidel Corporation Competitive Strengths & Weaknesses
Table 37. Roche Holding AG Basic Information, Area Served and Competitors
Table 38. Roche Holding AG Major Business
Table 39. Roche Holding AG Lyme Disease Testing Product and Services
Table 40. Roche Holding AG Lyme Disease Testing Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Roche Holding AG Recent Developments/Updates
Table 42. Roche Holding AG Competitive Strengths & Weaknesses
Table 43. Fujirebio(H.U. Group Holdings) Basic Information, Area Served and Competitors
Table 44. Fujirebio(H.U. Group Holdings) Major Business
Table 45. Fujirebio(H.U. Group Holdings) Lyme Disease Testing Product and Services
Table 46. Fujirebio(H.U. Group Holdings) Lyme Disease Testing Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. Fujirebio(H.U. Group Holdings) Recent Developments/Updates
Table 48. Fujirebio(H.U. Group Holdings) Competitive Strengths & Weaknesses
Table 49. ZEUS Scientific Basic Information, Area Served and Competitors
Table 50. ZEUS Scientific Major Business
Table 51. ZEUS Scientific Lyme Disease Testing Product and Services
Table 52. ZEUS Scientific Lyme Disease Testing Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. ZEUS Scientific Recent Developments/Updates
Table 54. ZEUS Scientific Competitive Strengths & Weaknesses
Table 55. IGeneX Basic Information, Area Served and Competitors
Table 56. IGeneX Major Business
Table 57. IGeneX Lyme Disease Testing Product and Services
Table 58. IGeneX Lyme Disease Testing Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. IGeneX Recent Developments/Updates
Table 60. IGeneX Competitive Strengths & Weaknesses
Table 61. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 62. Thermo Fisher Scientific Major Business
Table 63. Thermo Fisher Scientific Lyme Disease Testing Product and Services
Table 64. Thermo Fisher Scientific Lyme Disease Testing Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Thermo Fisher Scientific Recent Developments/Updates
Table 66. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 67. Everlywell Basic Information, Area Served and Competitors
Table 68. Everlywell Major Business
Table 69. Everlywell Lyme Disease Testing Product and Services
Table 70. Everlywell Lyme Disease Testing Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Everlywell Recent Developments/Updates
Table 72. Everlywell Competitive Strengths & Weaknesses
Table 73. Oxford Immunotec Global PLC(PerkinElmer) Basic Information, Area Served and Competitors
Table 74. Oxford Immunotec Global PLC(PerkinElmer) Major Business
Table 75. Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Product and Services
Table 76. Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Oxford Immunotec Global PLC(PerkinElmer) Recent Developments/Updates
Table 78. Oxford Immunotec Global PLC(PerkinElmer) Competitive Strengths & Weaknesses
Table 79. BioMerieux Basic Information, Area Served and Competitors
Table 80. BioMerieux Major Business
Table 81. BioMerieux Lyme Disease Testing Product and Services
Table 82. BioMerieux Lyme Disease Testing Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. BioMerieux Recent Developments/Updates
Table 84. BioMerieux Competitive Strengths & Weaknesses
Table 85. Bio-Rad Laboratories Basic Information, Area Served and Competitors
Table 86. Bio-Rad Laboratories Major Business
Table 87. Bio-Rad Laboratories Lyme Disease Testing Product and Services
Table 88. Bio-Rad Laboratories Lyme Disease Testing Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. Bio-Rad Laboratories Recent Developments/Updates
Table 90. T2 Biosystems Basic Information, Area Served and Competitors
Table 91. T2 Biosystems Major Business
Table 92. T2 Biosystems Lyme Disease Testing Product and Services
Table 93. T2 Biosystems Lyme Disease Testing Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 94. Lyme Disease Testing Raw Material
Table 95. Key Manufacturers of Lyme Disease Testing Raw Materials
Table 96. Lyme Disease Testing Typical Distributors
Table 97. Lyme Disease Testing Typical Customers

LIST OF FIGURES

Figure 1. Lyme Disease Testing Picture
Figure 2. World Lyme Disease Testing Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Lyme Disease Testing Total Market Size (2017-2028) & (USD Million)
Figure 4. World Lyme Disease Testing Market Size Market Share by Region (2017-2028)
Figure 5. United States Lyme Disease Testing Market Size (2017-2028) & (USD Million)
Figure 6. China Lyme Disease Testing Market Size (2017-2028) & (USD Million)
Figure 7. Europe Lyme Disease Testing Market Size (2017-2028) & (USD Million)
Figure 8. Japan Lyme Disease Testing Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Lyme Disease Testing Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Lyme Disease Testing Market Size (2017-2028) & (USD Million)
Figure 11. India Lyme Disease Testing Market Size (2017-2028) & (USD Million)
Figure 12. Lyme Disease Testing Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Lyme Disease Testing by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Lyme Disease Testing Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Lyme Disease Testing Markets in 2021
Figure 17. United States VS China: Lyme Disease Testing Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Lyme Disease Testing Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Lyme Disease Testing Market Size Market Share by Type in 2021
Figure 20. ELISA
Figure 21. Western Blotting
Figure 22. PCR
Figure 23. Others
Figure 24. World Lyme Disease Testing Market Size Market Share by Type (2017-2028)
Figure 25. World Lyme Disease Testing Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 26. World Lyme Disease Testing Market Size Market Share by Application in 2021
Figure 27. Hospital and Testing Agency
Figure 28. Personal
Figure 29. World Lyme Disease Testing Market Size Market Share by Application (2017-2028)
Figure 30. Manufacturing Cost Structure Analysis of Lyme Disease Testing in 2021
Figure 31. Manufacturing Process Analysis of Lyme Disease Testing
Figure 32. Lyme Disease Testing Industrial Chain
Figure 33. Distribution Channel Breakdown for Lyme Disease Testing Shipments (%): 2017-2028
Figure 34. Direct Channel Pros & Cons
Figure 35. Indirect Channel Pros & Cons
Figure 36. Methodology
Figure 37. Research Process and Data Source


More Publications